Q Biomed Inc.
Company Snapshot: Q Biomed Inc.
Q BioMed Inc. is a biomedical acceleration and development company. We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need.
By partnering with exceptional entrepreneurs we aim to help to create market-leading products and companies in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.
- Jan 16 2019 Q BioMed Adds Clinical Psychologist at Yale's Child Study Center, Dr. Pamela Ventola to Advisory Committee for QBM-001
- Jan 8 2019 Q BioMed Inc Provides Shareholder Update
- Dec 12 2018 Q BioMed Announces Strategic Partnership With SRI International for Formulation and Preclinical Development of QBM-001 for Pediatric Nonverbal Disorder in Autistic Children
- Nov 28 2018 Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron™ from GE Healthcare
- Oct 26 2018 Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference